Current status and future perspectives of bispecific antibodies in the treatment of lung cancer

Monoclonal antibodies have been successfully incorporated into the current therapeutical landscape of lung cancer in the last decades. Recently, with technological advances, bispecific antibodies (bsAbs) have also shown robust efficacy in the treatment of malignant cancers, including lung cancer. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wanying, Qiu, Tianyu, Li, Fei, Ren, Shengxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106182/
https://www.ncbi.nlm.nih.gov/pubmed/36848213
http://dx.doi.org/10.1097/CM9.0000000000002460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106182/
https://www.ncbi.nlm.nih.gov/pubmed/36848213
http://dx.doi.org/10.1097/CM9.0000000000002460

Ejemplares similares